ASRS
RETA

Arizona State Retirement System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Arizona State Retirement System’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,762
Closed -$689K – 2201
2023
Q2 		$689K Sell
6,762
-1,052
-13% -$99.6K 0.01% 1234
2023
Q1 		$710K Buy
7,814
+239
+3% +$14K 0.01% 1203
2022
Q4 		$288K Buy
+7,575
New +$261K ﹤0.01% 1703
2022
Q3 		– Sell
-7,250
Closed -$220K – 2250
2022
Q2 		$220K Buy
7,250
+19
+0.3% +$567 ﹤0.01% 1872
2022
Q1 		$237K Buy
+7,231
New +$215K ﹤0.01% 1940
2021
Q4 		– Sell
-7,263
Closed -$731K – 2304
2021
Q3 		$731K Buy
7,263
+84
+1% +$9.85K 0.01% 1301
2021
Q2 		$1.02M Buy
7,179
+44
+0.6% +$4.97K 0.01% 1106
2021
Q1 		$711K Buy
7,135
+95
+1% +$11.1K 0.01% 1337
2020
Q4 		$870K Sell
7,040
-184
-3% -$24.2K 0.01% 1130
2020
Q3 		$704K Buy
7,224
+1,869
+35% +$234K 0.01% 1114
2020
Q2 		$835K Buy
5,355
+253
+5% +$38.5K 0.01% 845
2020
Q1 		$736K Buy
+5,102
New +$985K 0.01% 804

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arizona State Retirement System's RETA Position: Q3 2023 in Review

Arizona State Retirement System sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 6,762 shares — an estimated $689K sold.

Arizona State Retirement System first reported a position in RETA in Q1 2020 and held it in 12 quarters. The position peaked at $1.02M in Q2 2021. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Arizona State Retirement System reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 6,762 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $689K.
  • Arizona State Retirement System first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2020 and held it in 12 quarters.
  • Arizona State Retirement System's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.02M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Arizona State Retirement System's 13F filing for Q3 2023, filed 7 Nov 2023.